Position in TEVA
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$14,082,967
+$14,063,596 QoQ
Shares Held
467,562
+21647.1% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Candriam S.C.A. holds $163,728,631 across 5 Drug Manufacturers - Specialty & Generic names. TEVA ranks #5 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
458,854 | $54,241,131 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
63,066 | $37,396,876 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
275,064 | $36,236,931 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
2,286,841 | $21,770,726 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
467,562 | $14,082,967 |
All Filings in TEVA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,082,967 | 467,562 | Shares | Sole | 2026-04-30 | |
| 2020-09-30 | $19,371 | 2,150 | Principal | Sole | 2020-10-19 | |
| No filing history on record for this holder in this stock. | ||||||